Fundraising Fox
Comet Therapeutics
Cambridge, US · Founded 2018 · Delaware corporation · 5 known investors
Find your way into Comet Therapeutics
Sign up to see every warm intro you have to Comet Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Comet Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EK
ENEJ KUSCER, PH.D.Named on SEC filing
PV
PETER VAN VLASSELAER, PH.D.Named on SEC filing
HR
HENRIJETTE RICHTER, PH.D.Named on SEC filing
BM
BERNARDUS MACHIELSENamed on SEC filing
LD
LUCAS DE BREEDNamed on SEC filing
DD
DAVID DE GRAAF, PH.D.Named on SEC filing
AT
ART TAVERAS, PH.D.Named on SEC filing
Investors · 5
Mission Biocapitallisted by Mission BiocapitalSan Francisco · $500K
How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
Canaan PartnersreportedStamford · $500K – $20M
How we know: a partner's Signal profile · Not right? Tell us
Sofinnova PartnersreportedParis · $540K – $27M
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
SynconareportedLondon
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$14.1M disclosed across 1 round · 2019
▶$14.1MraisedJun 2019 · 4 investors · Other TechnologyRule 506(b)
▶$14.1MraisedJun 2019 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- ENEJ KUSCER, PH.D.Executive Officer
- PETER VAN VLASSELAER, PH.D.Director
- HENRIJETTE RICHTER, PH.D.Director
- BERNARDUS MACHIELSEDirector
- LUCAS DE BREEDDirector
- DAVID DE GRAAF, PH.D.Executive Officer, Director
- ART TAVERAS, PH.D.Executive Officer
- Offering amount
- $14.1M
- Amount sold
- $14.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Comet Therapeutics's investors?
- Comet Therapeutics's investors include Inkef, Mission Biocapital, Canaan Partners, Sofinnova Partners, Syncona.
- How much funding has Comet Therapeutics raised?
- Comet Therapeutics has disclosed $14.1M raised across 1 round.
- Where is Comet Therapeutics headquartered?
- Comet Therapeutics is headquartered in Cambridge, US.